ProductSafer
Subscribe
⚠️

Official recall

This notice was issued by U.S. Food & Drug Administration (FDA).

FDA

Thyroid Tablets, USP 30 mg recall: Super Potency

Official notice: Vitruvias Therapeutics, Inc Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency

AUBURN, Ala. (August 21, 2026) – Vitruvias Therapeutics, Inc. is voluntarily recalling one lot (Lot. No. 504950) of Thyroid Tablets, USP 30 mg to the consumer level. The product is being recalled because testing confirmed the potential for the product to be superpotent.

This recall was published by U.S. Food & Drug Administration (FDA). View the full official notice for complete details, affected product codes, and what to do next.

View the full official notice

Get an email when another product is recalled

A free Sunday round-up of new UK and US product recalls and safety warnings. Unsubscribe any time.

What should I do?

  • 1.Stop using the product immediately if you have it.
  • 2.Check the official notice for affected batch numbers, UPCs, or model numbers.
  • 3.Follow the instructions in the official notice for returns, replacements, or disposal.
  • 4.If you have health concerns after using the product, contact your doctor.

Latest recalls

Back to all recalls

ProductSafer is not affiliated with the FDA. This page reproduces publicly available recall information.

Never miss a finding

Get the latest health findings delivered to your inbox. Only the important stuff. No spam.

We'll send a confirmation email. Unsubscribe anytime.